SkinHealth Systems Inc. filings document the regulatory record for a Nasdaq-listed medical aesthetics company formerly known as The Beauty Health Company. The filings identify its Class A common stock, operating and financial results, non-GAAP reconciliations, and material-event disclosures tied to quarterly and annual reporting.
Its SEC record also includes proxy materials for annual stockholder voting, board and committee governance, director appointments, officer departures, compensatory arrangements, capital-structure disclosures and shareholder voting matters. These filings provide the formal disclosure framework for the company behind Hydrafacial, SkinStylus and related professional skin-health offerings.
The Beauty Health Company filed an amended report detailing the separation terms for former Chief Executive Officer Marla Beck, whose employment ended without cause effective September 30, 2025. She will serve in an advisory capacity from October 1 through no later than December 31, 2025, receiving her current compensation during this period, stated as $250,000 payable bi‑weekly.
Under the separation agreement, Ms. Beck will receive continued payment of Base Salary for eighteen months, a prorated bonus for the year of termination and any earned but unpaid prior‑year bonus, reimbursement of the employer portion of COBRA premiums for up to eighteen months, and up to $10,000 in legal fees. Her performance share units with a grant‑date value of $1,700,000 vest in full as of the Separation Date. The company states the departure did not arise from any disagreement related to financial reporting, operations, policies, or practices.
Beauty Health Co (SKIN) reporting person Pedro Bruno Ferreira Malha, who is President, CEO and a director, received restricted stock unit grants on 10/09/2025 that total 2,190,384 Class A common shares when combined across two grant lines. The filing shows 1,228,846 and 961,538 RSUs granted at an indicated per-share figure of $1.56. The RSUs vest in three equal annual installments beginning on the first anniversary of the grant, subject to continued service and certain acceleration rights, and are reported as directly owned following the grant.
The report was signed by an attorney-in-fact on 10/10/2025. No derivative securities or other transactions are disclosed. This filing documents an equity grant to align the CEO/director with shareholder interests through multi-year vesting rather than a sale or purchase of existing shares.
Initial Form 3 filed for Beauty Health Co (SKIN) reports that Pedro Bruno Ferreira Malha, listed as President and CEO and a director, filed an initial Section 16 statement for an event dated 10/01/2025. The filing states no securities are beneficially owned by the reporting person and includes an Exhibit 24 power of attorney. The form was signed by an attorney-in-fact on 10/10/2025.
The Beauty Health Company appointed Hatem Malha as President, CEO and director and disclosed the material terms of his employment agreement. His base salary will be $800,000 per year (pro-rated if partial year). He will receive a $450,000 one-time cash bonus payable within 14 days of the effective date that is repayable if he resigns without specified cause or is fired for cause within 12 months. He is eligible for an annual performance bonus targeted at 125% of base salary and two one-time equity awards: an Initial equity grant of $2,556,000 split 75% in RSUs and 25% in PSUs, and a 2025 equity grant of $2,000,000 split 75% RSUs and 25% PSUs, each subject to board approval and the company's Incentive Plan vesting terms.
Mirabella Financial Services LLP reported beneficial ownership of 12,790,383 shares of Beauty Health Company (common stock), representing 10.21% of the class. The filing states these shares are held on behalf of Blue Riband Fund LP, for which Mirabella acts as investment manager and has sole voting and dispositive power over the reported shares. The filing notes the holdings were acquired in the ordinary course of business and not for the purpose of changing or influencing control. The issuer's principal executive office is listed in Long Beach, California.
The Beauty Health Company (SKIN) filed a Current Report on Form 8-K reporting a material event dated September 4, 2025. The filing incorporates by reference a Supplemental Indenture No. 1 dated September 4, 2025 among The Beauty Health Company, the guarantors party thereto and U.S. Bank Trust Company, National Association, acting as trustee and collateral agent. The document includes an exhibit list and an embedded Inline XBRL cover page data file. The report is signed by Michael Monahan, Chief Financial Officer.
Janus Henderson Group plc reports beneficial ownership of 5,718,565 shares of The Beauty Health Company, representing 4.5% of the class. The filing indicates shared voting and shared dispositive power over those shares while noting no sole voting or dispositive power. The reporting person is organized in Jersey and identified as an investment adviser/holding company (IA, HC). The statement also discloses that indirect subsidiaries (JHIUS, JHIUKL and JHIAIFML) act as registered investment advisers providing advice to Managed Portfolios.
The Beauty Health Company (SKIN) Form 4 reports a non-sale withholding of shares by Chief Financial Officer Michael P. Monahan related to the vesting of restricted stock units. On 08/10/2025, 32,357 shares were withheld to satisfy tax withholding at a recorded price of $1.89 per share. The disclosure states this withholding "does not represent a sale." Following the transaction, the reporting person’s beneficial ownership is shown as 1,326,305 shares.
This filing documents an internal compensation settlement (tax withholding on vested RSUs) rather than an open-market transaction, and it clarifies the officer’s post-transaction share count.